Learn what hurdles must be overcome while conducting effective clinical research in a pandemic scenario, and the advantages of having an established pandemic preparedness and rapid response model in place.
TORONTO (PRWEB)
October 17, 2022
The unprecedented disruptions caused by the COVID-19 pandemic were felt across the drug development industry, triggering renewed interest from government, biotech and biopharma entities alike to invest in pandemic preparedness initiatives.
PPD, part of Thermo Fisher Scientific, immediately recognized an industry-wide, unmet need to safeguard against future disruptions to the clinical development process and spearheaded the generation of a pandemic preparedness and rapid response delivery model. This program represents an executable action plan to deliver high-quality clinical data in the face of rapidly changing regulatory landscapes, compressed timelines and resourcing challenges.
The featured speakers will discuss how they integrated lessons learned from the COVID-19 pandemic into an executable action plan to: Streamline feasibility and start-up processes; Build safeguards into bioprocess and manufacturing; Leverage digital tools to enhance regulatory intelligence and the patient journey; And more.
Register for this webinar to learn what hurdles must be overcome while conducting effective clinical research in a pandemic scenario, and the advantages of having an established pandemic preparedness and rapid response model in place.
Join experts from Thermo Fisher Scientific, Vanessa Elharrar, MD, MPH, Vice President, Vaccines Business Strategy Lead, PPD; Kelly Howard, Vice President, Commercial Operations Global Viral Vector Services and Advanced Therapies (mRNA, pDNA, Cell Therapy), Pharma Services Group, Thermo Fisher Scientific; Jennifer Crager, Executive Director, Digital and Decentralized Solutions, PPD; Dr. Ilse-Maria Nolan, Senior Director Regulatory Affairs, PPD; and Jenna McDonnell (BSc), Senior Director, Consulting, Innovation & Strategy, PPD, for the live webinar on Monday, October 31, 2022, at 11am EDT (3pm GMT/UK).
For more information, or to register for this event, visit Pandemic Preparedness & Rapid Response — Managing Clinical Research During a Public Health Emergency.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: